MCP-1 plasma levels were also measured in AD patients, subjects with cognitive impairment but no dementia (CIND) and healthy elderly followed up for five years and levels of MCP-1 were correlated with cognitive deterioration. The gene discussed is CCL2; the disease is Cognitive impairment.